Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5
Yu Kaku, Yusuke Kosugi, Keiya Uriu, Jumpei Ito, Alfredo A. Hinay, Jin Kuramochi, Kenji Sadamasu, Kazuhisa Yoshimura, Hiroyuki Asakura, Mami Nagashima, Kei Sato
Topics & Concepts
InfectivitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyLineage (genetic)Coronavirus disease 2019 (COVID-19)BiologyRecombinant DNAGeneVirusGeneticsMedicineDiseaseInternal medicineInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchPlant Virus Research StudiesViral gastroenteritis research and epidemiology